Navigation Links
ImmunoVaccine Technologies Receives $3 Million From ACOA
Date:1/21/2008

HALIFAX, Jan. 21 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a clinical stage vaccine development company, will receive $3 Million from the Atlantic Canada Opportunities Agency (ACOA), under the Atlantic Innovation Fund (AIF). This funding will enable IVT to undertake a $6 million project to develop new potent immune enhancement systems.

"Having ACOA recognize the market potential of our innovative vaccine platform is a tremendous boost," commented Brian Lowe, Vice President of IVT. "This funding will enable us, over the next three years, to create novel vaccines for the treatment of cancer and infectious diseases.

This funding announcement is the maximum grant awarded to a private company under Round V of the AIF. The funds will further IVT's research collaborations and commercialization opportunities with pharmaceutical companies worldwide.

Atlantic Innovation Fund investments were announced earlier today by The Honourable Peter MacKay, Minister of National Defence and Minister of the Atlantic Canada Opportunities Agency. The Atlantic Innovation Fund is designed to increase leading edge research and development (R&D) in Atlantic Canadian research facilities, leading to the launch of new ideas, products, processes and services.

About the VacciMax(R) Platform

ImmunoVaccine Technologies Inc. (IVT) has developed a breakthrough vaccine-enhancement technology - the VacciMax(R) platform. It is comprised of a mixture of liposomes and adjuvants. The VacciMax(R) platform is able to stimulate an earlier, more powerful, long lasting immune response that could provide a new way to treat a wide range of diseases.

The opportunities for market applications and medical benefits for the VacciMax(R) platform are broad, and include prostate, breast, cervical, ovarian, colon and lung cancer treatments, as well as vaccines for pandemic influenza and other infectious diseases. '/>"/>

SOURCE ImmunoVaccine Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. ImmunoVaccine Technologies Inc. to Acquire Immunotope Inc.
2. National report calls for more research on health effects of wireless technologies
3. VNUS Medical Technologies Appoints Peter Osborne as Chief Financial Officer
4. ReBuilder Medical Technologies, Inc. Expands R&D of New Products
5. Global Med Technologies(R) Adds Eighth SafeTrace Tx(R) Client in New York State
6. ReBuilder Medical Technologies, Inc. Announces Televised Broadcast
7. OneMedPlace Emerging Healthcare Technologies Finance Forum Jan 7, 8th
8. ReBuilder Medical Technologies, Inc. 4th Quarter Sales Increase 100% Exceeding Projections
9. Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Greenway(R) Medical Technologies
10. Settlement Reached Between Dilon Technologies and Naviscan on Patent Rights
11. BAXL Technologies Partners With Epikinonia at Maternity Clinic in Athens, Greece
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 Access MediQuip, ... implant management company, announced today that it has expanded ... of the nation's largest health benefits companies, with more ... and approximately 66 million individuals served through its subsidiaries. ... national surgical implant management program agreement back in 2008. ...
(Date:5/21/2013)... Beginning May 21st, 2013, DTP Sales & Service ... newest in digital recording technology, to the hands of ... anyone looking to get the most from technology professional ... is expected to have revolutionary options and impeccable design. ... features and highlights: ,      ...
(Date:5/21/2013)... May 21, 2013 Tools4ever, the market ... made its Self Service Reset Password Management (SSRPM) suitable ... can now use the service on mobile systems i.e.; ... users can easily reset their Windows passwords anywhere, anytime. ... questions correctly, the user may then reset his or ...
(Date:5/21/2013)... Alan Mozes HealthDay Reporter , , MONDAY, ... used by millions of people with chronic obstructive ... cardiovascular complications among older patients, a new large ... patients over age 65 who are prescribed long-acting ... beta-agonists (such as Serevent). Both medications are commonly ...
(Date:5/21/2013)... The surgical management of non-small cell lung cancer (NSCLC) ... of the patient, according to a new study., "In ... Stage II NSCLC is surgery," said researcher Jayanth Adusumalli, ... Nebraska. "In our study of more than 1,200,000 patients ... 2000 and 2010, we found statistically significant racial disparities ...
Breaking Medicine News(10 mins):Health News:Access MediQuip and WellPoint Renew and Expand National Contract for Implantable Medical Devices 2Health News:Access MediQuip and WellPoint Renew and Expand National Contract for Implantable Medical Devices 3Health News:DTP Sales & Service Announces Upcoming Availability Of Philips Pocket Memo 8000 Series 2Health News:Tools4ever’s password reset software ready for BYOD 2Health News:Certain COPD Meds Might Raise Heart Risks, Study Says 2Health News:Certain COPD Meds Might Raise Heart Risks, Study Says 3
... Senior Vice President Brent Rickles Explains How to Protect ... ... Scottsdale, Ariz. (PRWEB) September 10, 2008 ... security management, launches a customer http://www.lumension.com/request_form.jsp?id=142756&rpLeadSourceId=1 [podcast ...
... recently launched to the online scene to cater to people who ... moments. Pampering one,s self is a most deserved treat for ... ... 10, 2008 -- Premised upon totally hassle-free virtual shopping, www.personalcaredeals.com ...
... Medicare; identifies best options and guides people through the process ... ... Ill. (Vocus) September 10, 2008 -- http://www.allsup.com/ [Allsup] ... individuals with disabilities with the introduction of http://www.allsup.com/Medicare-Advisor.aspx ...
... DSM Pharmaceutical Products,(DPP) announced today the ... of,record for marketing services. This relationship, in ... DSM business group and its three business,units: ... Pharmaceuticals, Inc., DSM Pharmaceutical Products offers ...
... private equity investors have increasingly targeted nursing homes ... anecdotal evidence that these deals led to worsened ... under increased federal scrutiny. , But according ... premature. Private equity purchases of nursing homesmany of ...
... C14-UBT are the most commonly used non-invasive tests of ... depend also on the prevalence of H. pylori ... tests depend also on the prevalence of H. pylori ... higher sensitivity and lower specificity. There are reports suggesting that ...
Cached Medicine News:Health News:Lumension Security Launches Podcast On Application Whitelisting: Keep The Bad Guys Out - Let The Good Guys In 2Health News:Lumension Security Launches Podcast On Application Whitelisting: Keep The Bad Guys Out - Let The Good Guys In 3Health News:Lumension Security Launches Podcast On Application Whitelisting: Keep The Bad Guys Out - Let The Good Guys In 4Health News:A One-Stop Online Shop For Personal Pampering Needs 2Health News:A One-Stop Online Shop For Personal Pampering Needs 3Health News:Allsup's New Medicare Advisor Program Helps People with Disabilities Make Sound Healthcare Coverage Decisions 2Health News:Allsup's New Medicare Advisor Program Helps People with Disabilities Make Sound Healthcare Coverage Decisions 3Health News:Allsup's New Medicare Advisor Program Helps People with Disabilities Make Sound Healthcare Coverage Decisions 4Health News:Allsup's New Medicare Advisor Program Helps People with Disabilities Make Sound Healthcare Coverage Decisions 5Health News:DSM Pharmaceutical Products Announces the Appointment of That's Nice LLC as Agency of Record for Marketing 2Health News:DSM Pharmaceutical Products Announces the Appointment of That's Nice LLC as Agency of Record for Marketing 3Health News:Private equity companies purchase nursing homes, but care does not suffer 2Health News:Private equity companies purchase nursing homes, but care does not suffer 3
(Date:5/21/2013)... and TARRYTOWN, N.Y. , May 21, ... and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that ... online the positive Phase 2a study results of dupilumab ... an investigational monoclonal antibody targeting the alpha subunit of ... of both IL-4 and IL-13, drivers of Th2 (Type ...
(Date:5/21/2013)... 2013  Healthcare organizations expanding into emerging markets like ... , India and ... shortcuts.  This is proving particularly challenging, considering the current ... change the dialogue around BRIC, as it is now ... building regional partnerships to build a sustainable business. ...
(Date:5/21/2013)... 2013 U.S. spending on specialty prescription drugs ... as cancer, multiple sclerosis and rheumatoid arthritis — is ... 2015, according to a forecast released today by Express ... ) "As we see what,s on ... to act so they can continue to offer an ...
Breaking Medicine Technology:Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 2Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 4U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 2U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 3U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 4U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 5
... June 2, 2011 As global food insecurity reaches ... how one company can impact this growing crisis. Today, ... 100,000 families globally through a partnership with Heifer International. ... and Company, a leading global pharmaceutical corporation, is also ...
... Siemens Healthcare (NYSE: SI) will ... workflow management solutions at the Society for Imaging Informatics ... 2011, (booth 825) in the Gaylord National Resort and ... facing increased pressure to provide faster, more accurate diagnoses ...
Cached Medicine Technology:Elanco Announces Commitment to Fight World Hunger 2Elanco Announces Commitment to Fight World Hunger 3At SIIM 2011 Siemens Showcases Imaging IT Solutions for Driving Greater Value in Radiology and Other Specialties 2At SIIM 2011 Siemens Showcases Imaging IT Solutions for Driving Greater Value in Radiology and Other Specialties 3At SIIM 2011 Siemens Showcases Imaging IT Solutions for Driving Greater Value in Radiology and Other Specialties 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: